La
oficina de proyectos
internacionales del IIS
Aragón ha creado este
boletín mensual mediante
el cual se va a informar
de las convocatorias de
proyectos que se
encuentran abiertas, los
eventos y las jornadas que
puedan resultar
interesantes al respecto
para el personal
investigador y de
gestión.
Si quieres contactar con
la oficina de proyectos
internacionales puedes
hacerlo a través de esta
dirección de correo
electrónico:
internacional@iisaragon.es
Convocatorias
actuales
NOV
Horizon
Europe - ERC
Synergy Grants (ERC-2023-SyG)
The
aim is to provide
support for a small
group of two
to four Principal
Investigators to
jointly address
ambitious research
problems that
could not be
addressed by the
individual
Principal
Investigators and
their teams
working alone.
Synergy projects
should enable
substantial advances
at the frontiers of
knowledge, stemming,
for example, from
the
cross-fertilization
of scientific
fields, from new
productive lines of
enquiry, or new
methods and
techniques,
including
unconventional
approaches and
investigations at
the interface
between established
disciplines. The
transformative
research funded by
Synergy Grants
should have the
potential of
becoming a benchmark
on a global scale.
Chronic
pain imposes a
massive burden to
the individual, the
health system, and
the economy
worldwide. It leads
to a severe
reduction in the
quality of life of
those affected and
their families.
Patients' daily
activities such as
work and social
interactions are
heavily impaired. As
a consequence,
chronic pain can
lead to sleep
problems, depression
and anxiety. The
underlying
mechanisms are often
not understood.
Thus, joined efforts
of basic scientist,
clinicians, lay
organisations, and
policymakers are
needed to understand
the pathophysiology,
improve diagnosis
and therapy,
increase awareness,
and improve the
every-day life of
the patients. The
success of
biomedical research
however, is hampered
by the lack of
harmonization of
procedures,
experimental
methodologies, and
data management. For
the translation and
implementation of
future research
outcomes into
clinical practice,
as well as for
shaping future
research priorities,
it is essential to
form synergies in
the research
community, to
overcome gaps and
hurdles, to build
overarching
networks, and to
generate harmonizing
concepts and ideas.
Thus, a networking
call in the field of
chronic pain is now
launched under the
umbrella of the
ERA-NET NEURON.
Las
organizaciones
académicas o no
académicas de un
Estado miembro de la
UE o de un país
asociado a Horizonte
Europa pueden
solicitar ayudas a
través de
MSCA4Ukraine en
nombre de uno o
varios
investigadores que
cumplan los
criterios de
admisibilidad.
Cuantía de
2,000,000€/organización.
Los investigadores
deben:
• Ser nacionales
ucranianos, o
apátridas, o
nacionales de
terceros países
distintos de
Ucrania, con su
residencia principal
en Ucrania el 24 de
febrero de 2022.
• O bien haber sido
desplazados el 24 de
febrero de 2022 o
después, o están
dispuestos a
reubicarse desde
Ucrania.
• Ser
investigadores
postdoctorales o
doctorandos en el
momento en que se
vaya a iniciar la
beca.
• Tener los
conocimientos
lingüísticos
necesarios para
llevar a cabo con
éxito sus
actividades de
investigación en la
organización de
acogida prevista,
según lo confirmado
por la organización
de acogida en la
solicitud.
EHDEN
– European Health
Data and Evidence
Network (Cascade
funding)
IMI2-2017-12-04:
GA806968 EHDEN Data
Partner Call 7. In
Data Partner Calls,
funding can be
requested for the
following types of
activities:
A. Create new Data
Transformation and
Analytical
Infrastructure This
activity is intended
for Data Partners
that have not
started to map their
data to the OMOPCDM
yet.
B. Revise Existing
Data Transformation
and Analytical
Infrastructure.
C. Inspect Completed
Data Transformation
and Analytical
Infrastructure.
The Data Partner can
only apply for one
of the types of
activity above per
call but could
potentially apply
for funding for
multiple types of
activities during
the course of the
EHDEN project.
However, the total
amount of funding
granted for any one
institution,
counting all types
of grants awarded
during the EHDEN
project, cannot
exceed 100.000 Euro.
The
call for Research
Mobility Fellowships
aims to support PhD
students, Postdocs
and medical doctors
in training to
undertake scientific
visits fostering
specialist research
training outside
their countries of
residence.
The exchange can be
carried out either:
• within the same
ERN (Full Members
and Affiliated
Partners), OR
• between
different ERNs (Full
Members and
Affiliated
Partners), OR
• between ERN
Full Members /
Affiliated Partners
and non-ERN
institutions.
Successful
applicants should
acquire new
competences and
knowledge related to
their research on
rare diseases, with
a defined research
plan and
demonstrable benefit
to the ERN of the
home and/or host
institution.
The research
mobility fellowships
are meant to cover
stays of 4 weeks to
6 months duration.
MSCA
Doctoral Networks
will implement
doctoral programmes,
by partnerships of
universities,
research
institutions and
research
infrastructures,
businesses including
SMEs, and other
socio-economic
actors from
different countries
across Europe and
beyond. MSCA
Doctoral Networks
are indeed open to
the participation of
organisations from
third countries, in
view of fostering
strategic
international
partnerships for the
training and
exchange of
researchers.These
doctoral programmes
will respond to
well-identified
needs in various
R&I areas,
expose the
researchers to the
academic and
non-academic
sectors, and offer
training in
research-related, as
well as transferable
skills and
competences relevant
for innovation and
long-term
employability (e.g.
entrepreneurship,
commercialisation of
results,
Intellectual
Property Rights,
communication).
In line with the
strategic priority
of “Deepening the
ERA” this part will
support further
progress on the free
circulation of
knowledge in an
upgraded, efficient
and effective
R&I system. The
destination will be
pursued both at the
level of individual
researchers e.g.
helping to develop
the skills that
researchers need for
excellent science
and, connecting all
actors across Europe
and at the level of
institutions and
smaller research
teams around future
ERA Chair holders.
NOV
Horizon
Europe – Cluster 4
Digital and
emerging
technologies for
competitiveness
and fit for the
green deal
Collaborative
Research in
Computational
Neuroscience (CRCNS)
Through
the CRCNS program,
the U.S. National
Science Foundation
(NSF), National
Institutes of Health
(NIH), and
Department of Energy
(DOE); the German
Federal Ministry of
Education and
Research
(Bundesministerium
für Bildung und
Forschung, BMBF);
the French National
Research Agency
(Agence Nationale de
la Recherche, ANR);
the United
States-Israel
Binational Science
Foundation (BSF);
Japan’s National
Institute of
Information and
Communications
Technology (NICT);
and Spain’s State
Research Agency
(Agencia Estatal de
Investigación, AEI)
and National
Institute of Health
Carlos III
(Instituto de Salud
Carlos III, ISCIII)
support
collaborative
activities that will
advance the
understanding of
nervous system
structure and
function, mechanisms
underlying nervous
system disorders,
and computational
strategies used by
the nervous system.
Two classes of
proposals will be
considered in
response to this
solicitation:
Research Proposals
describing
collaborative
research projects,
and
Data Sharing
Proposals to enable
sharing of data and
other resources.
Horizon
Europe – Clúster 3
Disaster-Resilient
Society 2022
HORIZON-CL3-2022-DRS-01-01:
Enhanced citizen
preparedness in the
event of a disaster
or crisis-related
emergency. HORIZON-CL3-2022-DRS-01-02:
Enhanced
preparedness and
management of
High-Impact
Low-Probability or
unexpected events. HORIZON-CL3-2022-DRS-01-04:
Better understanding
of citizens’
behavioural and
psychological
reactions in the
event of a disaster
or crisis situation
(RIA). HORIZON-CL3-2022-DRS-01-07:
Improved
international
cooperation
addressing first
responder capability
gaps.
NOV
Horizon
Europe – Europe
Defence Fund (EDF)
EDF-2022-RA-MCBRN-HICP:
Diagnostics,
treatment, transport
and monitoring of
highly contagious,
injured and/or
contaminated
personnel.
DIC
EJP
RD – Networking
Support Scheme
(NSS)
The
first aim of the
Networking Support
Scheme in the
European Joint
Programme on Rare
Diseases (EJP RD) is
to encourage sharing
of knowledge on rare
diseases or rare
cancers between
health care
professionals,
researchers and
patients in new or
expanding research
networks by funding
networking events.
The second aim of
the Networking
Support Scheme is to
enable or increase
the participation of
usually
underrepresented
countries in Europe
in new and in
expanding research
networks on rare
diseases or rare
cancers.
The scheme will
provide financial
support to
applicants to
organize workshops
or conferences.
These workshops or
conferences are
meant to
1. Form new research
networks or expand
existing research
networks;
2. Strengthen
collaborations
between different
stakeholders in
different countries;
3. Enable the
exchange of
knowledge.
4. These workshops
or conferences
should be (the
implications of)
research results and
innovative
solutions. The
results of these
networking events
may lead to future
collaborative and
novel research
efforts.
Horizon
Europe – ERC Proof
of Concept Grant
(ERC-2023-POC)
Horizon
Europe – ERC Proof
of Concept Grant
(ERC-2023-POC)
The ERC Proof of
Concept Grants aim
at facilitating
exploration of the
commercial and
social innovation
potential of ERC
funded research, by
funding further work
(i.e. activities
which were not
scheduled to be
funded by the
original ERC
frontier research
grant) to verify the
innovation potential
of ideas arising
from ERC funded
projects. Proof of
Concept Grants are
therefore on offer
only to Principal
Investigators whose
proposals draw
substantially on
their ERC funded
research.
The financial
contribution will be
awarded as a lump
sum of EUR 150 000
for a period of 18
months.
The ERC expects
that, normally,
proof of concept
activities should be
completed within 12
months. However, to
allow for those
projects that
require more
preparation time,
the grant agreements
will be signed for
18 months.
Extensions of the
duration of proof of
concept projects may
be granted only
exceptionally.The
lump sum will cover
the beneficiaries'
direct and indirect
eligible costs for
the project: if the
project is
implemented
properly, the
amounts will be paid
regardless of the
costs actually
incurred. The lump
sum has been
designed to cover
the beneficiaries’
personnel costs,
subcontracting,
purchase costs,
other cost
categories, and
indirect costs.
All Principal
Investigators in
an ongoing ERC
main grant or in a
ERC main grant
that has ended
less than 12
months before 1
January 2023,
are eligible to
apply for an ERC
Proof of Concept
Grant.
Horizon
Europe – ERC
Consolidator Grant
(ERC-2023-COG)
The
ERC Consolidator
Grants are designed
to support excellent
Principal
Investigators at the
career stage at
which they may still
be consolidating
their own
independent research
team or programme.
Principal
Investigators must
demonstrate the
ground-breaking
nature, ambition and
feasibility of their
scientific proposal.
Consolidator Grants
may be awarded up to
a maximum of EUR
2 000 000
for a period of 5
years.
The maximum size of
the grants is
reduced pro rata
temporis for
projects of a
shorter duration.
(This does not apply
to ongoing
projects).
The Principal
Investigators shall
have been awarded
their first PhD at
least 7 and up to
12 years prior to
1 January 2023.
Cut-off dates: PhD
awarded from 1
January 2011 to 31
December 2015
(inclusive).
MSCA
COFUND co-finances
new or existing
doctoral programmes
and postdoctoral
fellowship schemes
with the aim of
spreading the best
practices of the
MSCA including
international,
inter-sectoral and
interdisciplinary
research training,
as well as
international and
cross-sectoral
mobility of
researchers at all
stages of their
career.
In practice, MSCA
COFUND provides
complementary
funding for doctoral
or postdoctoral
programmes managed
by entities
established in EU
Member States or
Horizon Europe
Associated
Countries. Those
co-funded programmes
must follow MSCA’s
good practice in
terms of
international
recruitment and
minimum standard of
employment for the
recruited fellows as
described in the
European Charter for
Researchers and Code
of Conduct for the
Recruitment of
Researchers.
Opening date:
11/10/2022
EU4H-2022-PJ-11:
Call for proposals
on prevention of
NCDs -
cardiovascular
diseases, diabetes
and other NCDs EU4H-2022-PJ-12:
Call for proposals
on cancer and other
NCDs prevention –
action on health
determinants EU4H-2022-PJ-14:
Call for proposals
to support the
roll-out of the
second cohort of the
inter-speciality
cancer training
programme
MSCA
Staff Exchanges
promote innovative
international,
inter-sectoral and
interdisciplinary
collaboration in
research and
innovation through
exchanging staff and
sharing knowledge
and ideas at all
stages of the
innovation chain.
The scheme fosters a
shared culture of
research and
innovation that
welcomes and rewards
creativity and
entrepreneurship and
helps turn ideas
into innovative
products, services
or processes. It is
open to research,
technical,
administrative, and
managerial staff
supporting R&I
activities.
The
climate crisis is
increasingly affecting our
health and wellbeing. In
August this year, around
the same time when
millions of Europeans
suffered from
record-breaking high
temperatures, new research
published in the science
journal Nature suggested
that climate change can
aggravate over half of
known human pathogenic
diseases.
Developed under the
European Climate and
Health Observatory
initiative, the new
European Environment
Agency report ‘Climate
change as a threat to
health and well-being in
Europe: focus on heat and
infectious diseases’ puts
these two threats in sharp
focus, and it outlines
solutions in policy and
practice.
The webinar is open to all
stakeholder after
registration
Strengthening
health systems: improving
population health and
being prepared for the
unexpected
The 15th
European Public Health
Conference will take
place in person in
November 2022 in Berlin.
Many sessions across the
conference tracks are
related to the PHIRI
activities. Some are
organised or co-hosted by
PHIRI, others involve
PHIRI members. We are
happy to share with you a
first overview of these
sessions. More details
will be communicated soon
on the PHIRI website.
For more information about
the conference and
registration, please
visit: www.ephconference.eu
Los
ERC Proposal
Reading Days
son una iniciativa donde
personas candidatas al
Consejo Europeo de
Investigación (ERC, en sus
siglas en inglés) tendrán
la oportunidad de leer
propuestas (disponibles
como copias en papel) que
resultaron financiadas en
alguna de las
convocatorias 2014-2021 de
dicho programa.
Esta sesión está abierta a
todas las personas
candidatas y elegibles en
las convocatorias 2023 de
ERC en sus modalidades
Consolidator y Advanced
Grants, Proof of Concept,
y Starting Grant 2024 y
que participen con una
institución de acogida
española.
Planned a few
weeks before the call
deadline, the
purpose of the second
information webinar is to
remind the Call ORD
expectations and answer
last-minute questions:
• CHIST-ERA and Call
ORD key features
• Proposal preparation
recommendations
• How to submit your
proposal
Primary
care is in the heart of
community mental health
care. Primary Care
professionals have
important roles in
referring patients to
specialized mental health
services, providing
integrated care for
physical and mental health
for co-existing conditions
(e.g. diabetes and
depression) and to serve
as the linking pin between
specialized care, primary
care and social services.
See also the EFPC position
paper on mental health.
Therefore, EFPC is happy
to collaborate with EUCOMS
(The European Community
Mental Health Service
providers network). We are
strongly connected and
have a Memorandum of
Understanding. We
recommend reading their
consensus paper with a
vision of a network
approach in community
mental health care.
In a joint webinar both
networks will shine a
light on an ecosystem
approach to mental health
in primary care. Chaired
by Dineke Smit (EFPC) and
Rene Keet (EUCOMS)
RARE2022
will follow on from the
success of its
predecessors, continuing
to address the challenges
of Rare Diseases. The
conference will expand on
“generic topics”, such as:
• the role of whole
genome sequencing
• screening strategies
• monitoring and
databases in rare diseases
• innovative therapies
• patient-centric
medicine
• current status of
several specific diseases
RARE2022
is honored to welcome
world-renowned speakers
from all 5 continents, all
of whom are experts in the
field of Rare Diseases and
who will present
ground-breaking and
cutting-edge news on
treatments in Rare
Diseases.
RARE2022
will bring together
experts from healthcare,
academia and industry
working in the field of
Rare Diseases treatment.
The
aim of the IHI Call Days
is to provide potential
applicants with the
information they need to
put together a strong
proposal and give them the
opportunity to identify
and meet partners for
their consortia.
The main activities of the
Call Days will be as
follows:
• Info sessions on the
rules and procedures and
financial part of the
proposal
• Info sessions on the
call topics
• Matchmaking sessions per
call topic
• Pitching sessions per
call topic
The following topics are
under consideration:
• Topic 1: Screening
platform and biomarkers
for prediction and
prevention of diseases of
unmet public health need
• Topic 2: Patient
generated evidence to
improve outcomes, support
decision making, and
accelerate innovation
• Topic 3: Combining
hospital interventional
approaches to improve
patient outcomes and
increase hospital
efficiencies
• Topic 4: Strengthening
the European ecosystem for
Advanced Therapy Medicinal
Products (ATMPs) and other
innovative therapeutic
modalities for rare
diseases
• Topic 5: Digital health
technologies for the
prevention and
personalised management of
mental disorders and their
long-term health
consequences
The
aim of the IHI Call Days
is to provide potential
applicants with the
information they need to
put together a strong
proposal and give them the
opportunity to identify
and meet partners for
their consortia.
The main activities of the
Call Days will be as
follows:
• Info session on the
rules and procedures
• Info sessions on the
call topics
The following topics are
under consideration:
• Topic 1: Expanding
translational knowledge in
minipigs: a path to reduce
and replace non-human
primates in non-clinical
drug safety assessment
• Topic 2:
Patient-centric blood
sample collection to
enable decentralised
clinical trials and
improve access to
healthcare
Registration
is now open to the yearly
5-day course on
“Translational Medicine
Explained (TMex) ” on 13-17
February 2023 in
Barcelona.
The course is intended for
PhD/MD students, postdocs
and other young scientists
who are involved in
biomedical research and
want to learn more about
Translational Medicine.
The TMex (“Translational
Medicine Explained)”
Winter School consists of
an introductory e learning
(~12 hours student
investment time) followed
by a 5-day face-to-face
workshop. The course is
intended for PhD/MD
students in the second
half of their PhD and
postdocs who are involved
in biomedical research.
The full fee is of 650€.
Special discounted fees of
475€ applies for EATRIS
members and I2TRON
students, and of 250€ for
VHIR students and EUPATI
fellows.
There are only 30 seats,
so we recommend applying
early (first come, first
served). The
registration will
close when all seats
have been filled.
You will need to submit a
biosketch and a motivation
letter which will be
reviewed by a selection
committee.
Contacto
Instituto de Investigación
Sanitaria Aragón (IIS Aragón)
Centro de Investigación
Biomédica de Aragón (CIBA)
Avda. San Juan Bosco, nº 13.
50009 - Zaragoza
Tfno. +34 976 71 64 17 | +34 976
71 44 02
Recibes este boletín porque eres
miembro del IIS Aragón o porque
estás interesado en sus
actividades. Si no deseas
recibirlo, por favor, ponte en
contacto con internacional@iisaragon.es
para tramitar la baja de la
suscripción.
